Substance use among HIV-infected adolescents in Uganda: rates and association with potential risks and outcome factors.
Adolescent
Alcohol Drinking
/ epidemiology
Anti-Retroviral Agents
/ therapeutic use
Black People
/ psychology
Cross-Sectional Studies
Female
HIV Infections
/ complications
Humans
Male
Mental Health
/ statistics & numerical data
Self Report
Substance-Related Disorders
/ epidemiology
Uganda
/ epidemiology
Africa
HIV positive adolescents
Substance use
negative outcomes
prevalence
risk factors
Journal
AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
pubmed:
2
2
2020
medline:
6
3
2021
entrez:
2
2
2020
Statut:
ppublish
Résumé
This article sets out to investigate alcohol and substance use (ASU) among adolescents living with HIV (ALWH) in the sub-Saharan African setting of Uganda. A cross-sectional analysis of the records of 479 adolescents (aged between 12and 17 years) attending the study, "Mental health among HIV infected CHildren and Adolescents in KAmpala and Masaka, Uganda (the CHAKA study)" was undertaken. ASU was assessed through both youth self-report and caregiver report using the Diagnostic and Statistical Manual of Mental Disorders-5 referenced instruments, the Youth Inventory-4R and the Child and Adolescent Symptom Inventory-5 (CASI-5). Rates and association with potential risk and outcome factors were investigated using logistic regression models. The rate of ASU was 29/484 (5.9%) with the most frequently reported ASU being alcohol 22/484 (4.3%) and marijuana 10/484 (2.1%). Functional impairment secondary to ASU was reported by 10/484 (2.1%) of the youth. ASU was significantly associated with urban residence, caregiver psychological distress and the psychiatric diagnosis of post-traumatic stress disorder. On associations with negative outcomes, ASU was significantly associated with only "ever had sex". Health care for ALWH in sub-Saharan Africa should include ASU prevention and management strategies.
Identifiants
pubmed: 32005076
doi: 10.1080/09540121.2020.1717419
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
137-147Subventions
Organisme : Wellcome Trust
ID : 205069/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1204/10
Pays : United Kingdom